JERRY SULLIVAN: Open Payments
NPI 1629062724 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 107 payments from 11 companies in 2025. Trend: 2023 $584 · 2024 $853 · 2025 $1,975
Food & beverage: $1,867Education: $108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $744 |
| Janssen Biotech, Inc. | 14 | $356 |
| Madrigal Pharmaceuticals | 12 | $296 |
| Aimmune Therapeutics, Inc. | 14 | $180 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $161 |
| Ardelyx, Inc. | 5 | $126 |
| QOL Medical, LLC | 1 | $43 |
| Verona Pharma, Inc. | 1 | $26 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $21 |
| Novo Nordisk Inc | 1 | $15 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, ZENPEP, XIFAXAN, SKYRIZI, IBSRELA, Linzess.
Industry payments across GA — which companies pay providers there.
